<DOC>
	<DOCNO>NCT00833495</DOCNO>
	<brief_summary>This phase 2 study consist 3 visit 3 week period conduct 5 site . The purpose study determine effective combination Pred Mild® FOV1101-00 compare either Pred Forte® alone vehicle alone prevention eye allergy . Study subject randomize one following : - FOV1101-00 concentration 1 Pred Mild® - FOV1101-00 concentration 2 Pred Mild® - Vehicle FOV1101-00 Pred Forte® - Vehicle FOV1101-00 Vehicle FOV1101-00</brief_summary>
	<brief_title>Evaluation Efficacy Coadministration FOV1101-00 Prednisolone Acetate Patients With Mild Ongoing Ocular Allergic Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>history ocular allergy positive skin test reaction allergen within past 24 month history chronic eye irritation ; active ocular infection ; clinically significant blepharitis ; follicular conjunctivitis ; iritis ; type glaucoma ; ocular surgery within past 3 month ; pregnancy nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>